부산대학교 도서관

Allaf ME; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Kim SE; Department of Data Science, Dana-Farber Cancer Institute/ECOG-ACRIN Biostatistics Center, Boston, MA, USA.; Master V; Department of Urology, Emory University, Altanta, GA, USA.; McDermott DF; Division of Medical Oncology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA.; Harshman LC; Department of Internal Medicine, Dana-Farber/Harvard Cancer Center, Boston, MA, USA.; Cole SM; Department of Internal Medicine, UT Southwestern/Simmons Cancer Center-Dallas, Dallas, TX, USA.; Drake CG; Milstein Hospital, New York, NY, USA.; Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Akgul M; Department of Pathology, Albany Medical Center, Albany, NY, USA.; Baniak N; Department of Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, SK, Canada.; Li-Ning E; Department of Translational Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA.; Palmer MB; Department of Pathology and Laboratory Medcine, University of Pennsylvania/Abramson Cancer Center, Philadelphia, PA, USA.; Emamekhoo H; Department of Medicine, Wisconsin Institute for Medical Research, Madison, WI, USA.; Adra N; Department of Hematology/Oncology, Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.; Kaimakliotis H; Department of Urology, Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.; Ged Y; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Pierorazio PM; Division of Urology, Department of Surgery, Penn Presbyterian Medical Center, Penn Medicine, Philadelphia, PA, USA.; Abel EJ; Department of Urology, University of Wisconsin Carbone Cancer Center, Madison, WI, USA.; Bilen MA; Department of Hematology and Medical Oncology, Emory University/Winship Cancer Institute, Atlanta, GA, USA.; Ogan K; Department of Urology, Emory University/Winship Cancer Institute, Atlanta, GA, USA.; Moon HH; Department of Research and Evaluation, Kaiser Permanente, Riverside, CA, USA.; Ramaswamy KA; Department of Urology, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.; Singer EA; Department of Urology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Mayer TM; Deparment of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Lohrey J; Department of Internal Medicine, UT Southwestern/Simmons Cancer Center-Dallas, Dallas, TX, USA.; Margulis V; Department of Urology, UT Southwestern/Simmons Cancer Center-Dallas, Dallas, TX, USA.; Gills J; Department of Urology, Louisiana State University Health Science Center, New Orleans, LA, USA.; Delacroix SE; Department of Urology, Louisiana Cancer Research Center, New Orleans, LA, USA.; Waples MJ; Department of Urology, Aurora Urology, Milwaukee, WI, USA.; James AC; Department of Urology, University of Kentucky/Markey Cancer Center, Lexington, KY, USA.; Wang P; Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Choueiri T; Department of Medical Oncology, Dana-Farber/Harvard Cancer Center, Boston, MA, USA.; Michaelson MD; Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Kapoor A; Department of Surgery, McMaster University, Hamilton, ON, Canada.; Heng DY; Department of Oncology, Tom Baker Cancer Centre, Calgary, AB, Canada.; Shuch B; Department of Urology, UCLA/Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.; Leibovich BC; Department of Urology, Mayo Clinic, Rochester, MN, USA.; Lara PN; Division Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.; Manola J; Department of Data Science, Dana-Farber Cancer Institute/ECOG-ACRIN Biostatistics Center, Boston, MA, USA.; Maskens D; International Kidney Cancer Coalition, Amsterdam NL, Guelph, ON, Canada.; Battle D; Kidney Cancer Research Alliance, Alexandria, VA, USA.; Uzzo R; Department of Urology, Fox Chase Cancer Center, Philadelphia, PA, USA.; Bratslavsky G; Department of Urology, SUNY Upstate Medical Center-Community Campus, Syracuse, NY, USA.; Haas NB; Department of Medicine, University of Pennsylvania/Abramson Cancer Center, Philadelphia, PA, USA; Perelman Center for Advanced Medicine, Philadelphia, PA, USA. Electronic address: naomi.haas@pennmedicine.upenn.edu.; Carducci MA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Choudhury AD; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Kwak L; Dana-Farber Cancer Institute, Boston, Massachusetts.; Cheung A; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Allaire KM; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Marquez J; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Yang DD; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Tripathi A; City of Hope Comprehensive Cancer Center, Duarte, California.; Kilar JM; Dana-Farber Cancer Institute, Boston, Massachusetts.; Flynn M; Dana-Farber Cancer Institute, Boston, Massachusetts.; Maynard B; Deciphera Pharmaceuticals, Waltham, Massachusetts.; Reichel R; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Pace AF; Dana-Farber Cancer Institute, Boston, Massachusetts.; Chen BK; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Van Allen EM; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Kilbridge K; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Wei XX; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; McGregor BA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Pomerantz MM; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Bhatt RS; Harvard Medical School, Boston, Massachusetts.; Beth-Israel Deaconess Medical Center, Boston, Massachusetts.; Sweeney CJ; South Australian Immunogenomics Centre, University of Adelaide, Adelaide, Australia.; Bubley GJ; Harvard Medical School, Boston, Massachusetts.; Beth-Israel Deaconess Medical Center, Boston, Massachusetts.; Jacene HA; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Taplin ME; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Huang FW; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Harshman LC; Dana-Farber Cancer Institute, Boston, Massachusetts.; Fong L; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Saliby RM; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; El Zarif T; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Bakouny Z; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Shah V; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Xie W; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Flippot R; Department of Cancer Medicine, Gustave Roussy, Paris Saclay University, Villejuif, France.; Denize T; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Kane MH; Yale Center of Cellular and Molecular Oncology, Yale School of Medicine, New Haven, Connecticut.; Madsen KN; Yale Center of Cellular and Molecular Oncology, Yale School of Medicine, New Haven, Connecticut.; Ficial M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Hirsch L; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Wei XX; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Steinharter JA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Larner College of Medicine, University of Vermont, Burlington, Vermont.; Harshman LC; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Surface Oncology, Cambridge, Massachusetts.; Vaishampayan UN; University of Michigan/Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.; Severgnini M; Center for Immuno-Oncology Immune Assessment Laboratory at the Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; McDermott DF; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Lee GM; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Xu W; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Van Allen EM; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; McGregor BA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Signoretti S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; McKay RR; Moores Cancer Center, University of California San Diego, La Jolla, California.; Braun DA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Yale Center of Cellular and Molecular Oncology, Yale School of Medicine, New Haven, Connecticut.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Duarte C; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, 1665 Aurora Ct. MS F704, Aurora, CO 80045, USA.; Hu J; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, 1665 Aurora Ct. MS F704, Aurora, CO 80045, USA.; Beuselinck B; Department of General Medical Oncology, University Hospitals Leuven, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.; Panian J; Moores Cancer Center University of California San Diego, San Diego, CA, USA.; Weise N; Moores Cancer Center University of California San Diego, San Diego, CA, USA.; Dizman N; City of Hope, Duarte, CA, USA.; Collier KA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Rathi N; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.; Li H; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.; Elias R; University of Texas Southwestern Medical Center, Dallas, TX, USA.; Martinez-Chanza N; Institut Jules Bordet, Brussels, Belgium.; Rose TL; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.; Harshman LC; Prior Institution: Dana-Farber Cancer Institute, Boston, MA, USA.; Current Institution: Surface Oncology, Cambridge, MA, USA.; Gopalakrishnan D; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Vaishampayan U; Prior Institution: Karmanos Cancer Center, Detroit, MI, USA.; Current Institution: Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.; Zakharia Y; Holden Comprehensive Cancer Center at University of Iowa, Iowa City, IA, USA.; Narayan V; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA, USA.; Carneiro BA; Legorreta Cancer Center at Brown University, Lifespan Cancer Institute, Providence, RI, USA.; Mega A; Legorreta Cancer Center at Brown University, Lifespan Cancer Institute, Providence, RI, USA.; Singla N; University of Texas Southwestern Medical Center, Dallas, TX, USA.; Meguid C; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, 1665 Aurora Ct. MS F704, Aurora, CO 80045, USA.; George S; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Brugarolas J; University of Texas Southwestern Medical Center, Dallas, TX, USA.; Agarwal N; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.; Mortazavi A; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Pal S; City of Hope, Duarte, CA, USA.; McKay RR; Moores Cancer Center University of California San Diego, San Diego, CA, USA.; Lam ET; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, 1665 Aurora Ct. MS F704, Aurora, CO 80045, USA.

Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

Chang SL; Harshman LC; Presti JC Jr; Chang, Steven L; Harshman, Lauren C; Presti, Joseph C Jr

Journal of Clinical Oncology; 9/1/2010, Vol. 28 Issue 25, p3951-3957, 7p

Hirsch L; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Martinez Chanza N; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Medical Oncology Department, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.; Farah S; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Xie W; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Flippot R; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Braun DA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rathi N; Huntsman Cancer Institute, Salt Lake City, Utah.; Thouvenin J; Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.; Collier KA; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus.; Seront E; Institut Roi Albert II, Department of Medical Oncology, St Luc University Hospital, Brussels, Belgium.; de Velasco G; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain.; Dzimitrowicz H; Duke Cancer Center, Durham, North Carolina.; Beuselinck B; Leuven Cancer Institute, Universitaire Ziekenhuizen, Leuven, Belgium.; Xu W; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Bowman IA; University of Texas Southwestern Medical Center, Dallas.; Lam ET; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora.; Abuqayas B; Holden Comprehensive Cancer Center, University of Iowa, Iowa City.; Bilen MA; Winship Cancer Institute, Emory University, Atlanta, Georgia.; Varkaris A; Beth Israel Deaconess Medical Center, Boston, Massachusetts.; Zakharia Y; Holden Comprehensive Cancer Center, University of Iowa, Iowa City.; Harrison MR; Duke Cancer Center, Durham, North Carolina.; Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus.; Barthélémy P; Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, France.; Agarwal N; Huntsman Cancer Institute, Salt Lake City, Utah.; McKay RR; Moores Cancer Center, University of California San Diego, La Jolla.; Brastianos PK; Mass General Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston.; Krajewski KM; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.; Albigès L; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Harshman LC; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Wong RL; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Ferris LA; Department of Medicine, University of Washington, Seattle, Washington, USA.; Do OA; Department of Medicine, University of Washington, Seattle, Washington, USA.; Holt SK; Department of Urology, University of Washington, Seattle, Washington, USA.; Ramos JD; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Crabb SJ; Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom.; Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, New York, USA.; Bellmunt J; Hospital Del Mar, Barcelona, Spain.; Ladoire S; Georges-François Leclerc Cancer Center, Dijon, France.; De Giorgi U; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy.; Harshman LC; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Vaishampayan UN; Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.; Necchi A; Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Italy.; Srinivas S; Stanford University, Palo Alto, California, USA.; Pal SK; City of Hope Comprehensive Cancer Center, Duarte, California, USA.; Niegisch G; Department of Urology, Medical Faculty, Heinrich-Heine-University, Germany.; Dorff TB; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.; Galsky MD; Mount Sinai Medical Center, New York, New York, USA.; Yu EY; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Montagnani F; Department of Oncology, Ospedale degli Infermi, Biella, Italy.; Nuzzo PV; Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Gonzalez-Velez M; Genomic Oncology Clinic, Mayo Clinic, Phoenix, Arizona.; Alimohamed NS; Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada.; Rosellini P; Department of Medical and Surgical Sciences and Neuroscience, University of Siena, Siena, Italy.; Moreno-Candilejo I; Medical Oncology Unit, Hospital HM Sanchinarro Start, Madrid, Spain.; Cigliola A; Department of Medical and Surgical Sciences and Neuroscience, University of Siena, Siena, Italy.; Rubio-Perez J; University Hospital Fundacion Jimenez Diaz, Autonomous University of Madrid, Madrid, Spain.; Crivelli F; Department of Oncology, Ospedale degli Infermi, Biella, Italy.; Shaw GK; Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Zhang L; DFCI at Geisinger Medical Center, Danville, Pennsylvania.; Petrioli R; Department of Medical and Surgical Sciences and Neuroscience, University of Siena, Siena, Italy.; Bengala C; Medical Oncology Unit, Misericordia Hospital, Grosseto, Italy.; Francini G; Department of Medical and Surgical Sciences and Neuroscience, University of Siena, Siena, Italy.; Garcia-Foncillas J; University Hospital Fundacion Jimenez Diaz, Autonomous University of Madrid, Madrid, Spain.; Sweeney CJ; Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Higano CS; Fred Hutchinson Cancer Research Center, University of Washington, Seattle.; Bryce AH; Genomic Oncology Clinic, Mayo Clinic, Phoenix, Arizona.; Harshman LC; Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Lee-Ying R; Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada.; Heng DYC; Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Petrylak DP; Yale Cancer Center, New Haven, Connecticut. daniel.petrylak@yale.edu.; Loriot Y; Gustave Roussy, INSERM U981, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.; Shaffer DR; New York Oncology Hematology Albany Medical Center, Albany, New York.; Braiteh F; Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada.; Powderly J; Carolina BioOncology Institute, Huntersville, North Carolina.; Harshman LC; Dana-Farber Cancer Institute, Boston, Massachusetts.; Conkling P; US Oncology Research, Virginia Oncology Associates, Norfolk, Virginia.; Delord JP; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Gordon M; HonorHealth Research Institute, Scottsdale, Arizona.; Kim JW; Yale Cancer Center, New Haven, Connecticut.; Sarkar I; Genentech, Inc, South San Francisco, California.; Yuen K; Genentech, Inc, South San Francisco, California.; Kadel EE 3rd; Genentech, Inc, South San Francisco, California.; Mariathasan S; Genentech, Inc, South San Francisco, California.; O'Hear C; Genentech, Inc, South San Francisco, California.; Narayanan S; Genentech, Inc, South San Francisco, California.; Fassò M; Genentech, Inc, South San Francisco, California.; Carroll S; Genentech, Inc, South San Francisco, California.; Powles T; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Do OA; School of Medicine, University of Washington School of Medicine, Seattle, WA.; Ferris LA; School of Medicine, University of Washington School of Medicine, Seattle, WA.; Holt SK; Department of Urology, University of Washington Medical Center, Seattle, WA.; Ramos JD; Seagen Inc, Bothell, WA.; Harshman LC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Plimack ER; Division of Genitourinary Medical Oncology, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.; Crabb SJ; University of Southampton, Clinical Trials Unit, MP131, Southampton General Hospital, Southampton, Hants, United Kingdom.; Pal SK; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA.; De Giorgi U; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola FC, Italy.; Ladoire S; Georges Francois Leclerc Cancer Center INSERM U1231, Dijon, France.; Baniel J; Department of Urology, Rabin Medical Center, Tel Aviv University, Petah Tikva, Israel.; Necchi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Vaishampayan UN; Department of Internal Medicine/Oncology, University of Michigan, Ann Arbor, MI.; Bamias A; Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Bellmunt J; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA.; Srinivas S; Department of Medicine/Oncology, Stanford Cancer Institute, Palo Alto, CA.; Dorff TB; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA.; Galsky MD; Department of Medicine, Division of Oncology, Mount Sinai Hospital, New York, NY.; Yu EY; Division of Oncology, Department of Medicine, University of Washington, Seattle Cancer Care Alliance, Seattle, WA. Electronic address: evanyu@uw.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE